Related references
Note: Only part of the references are listed.Positive Predictive Value of Non-Traumatic Bleeding Diagnoses in the Danish National Patient Register
Maja Thaarup et al.
CLINICAL EPIDEMIOLOGY (2023)
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study
Nour Al-Hussainy et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2022)
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Diana A. Gorog et al.
THROMBOSIS AND HAEMOSTASIS (2022)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis
Dhruvil Radadiya et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data
Aya Enomoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2021)
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
Ole-Christian W. Rutherford et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study
Soonil Kwon et al.
AMERICAN HEART JOURNAL (2020)
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation
So-Ryoung Lee et al.
STROKE (2019)
Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis
Wen-Qin Guo et al.
CLINICAL EPIDEMIOLOGY (2019)
Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland
Tanja Mueller et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
L. Staerk et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting
Ekta Yogeshkumar Pandya et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data
Inmaculada Hernandez et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2017)
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study
Neena S. Abraham et al.
GASTROENTEROLOGY (2017)
Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients
Morten Lamberts et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients
Steven Deitelzweig et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
Peter A. Noseworthy et al.
CHEST (2016)
Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin ROCKET AF Trial
Matthew W. Sherwood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of Patients
Cathrine Wildenschild et al.
CLINICAL EPIDEMIOLOGY (2014)
New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
I. Lisanne Holster et al.
GASTROENTEROLOGY (2013)
Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry
Thomas Andersen Rix et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2012)
The Danish National Prescription Registry
Helle Wallach Kildemoes et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
The Danish National Patient Register
Elsebeth Lynge et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
The Danish Civil Registration System
Carsten Bocker Pedersen
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark
Grann et al.
Clinical Epidemiology (2011)
Pseudo-observations in survival analysis
Per Kragh Andersen et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Share Paper
